Mercury Laboratories P/E Ratio
Current P/E Ratio
19.24
Moderate Valuation
Moderate - Fairly valued
Mercury Laboratories (MERCURYLAB) P/E ratio is 19.24 (Moderate), EPS (TTM) ₹40.28, current price ₹840.00 on BSE — Moderate - Fairly valued. Browse MERCURYLAB annual financials for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
P/E Ratio
19.24
Current Price
₹840.00
EPS (TTM)
₹40.28
Exchange
BSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
52.97
Sector Median
30.68
Sector Rank
#11 of 194
Sector Percentile
5.7%
MERCURYLAB P/E Ratio — Valuation Signal & Historical Context
Mercury Laboratories P/E 19.24 — signal: Fairly Valued. Analyse MERCURYLAB institutional holdings to track promoter, FII and institutional holdings.
- Trading at discount to sector average PE of 52.97
MERCURYLAB vs Healthcare Peers — P/E Ratio Comparison
Mercury Laboratories P/E 19.24 vs Healthcare average 52.97, median 30.68 — range 2.86–850.0.
Sector Average
52.97
Sector Median
30.68
Lowest P/E
2.86
Highest P/E
850.0
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.64 | ₹29 | Low |
| Phaarmasia | PHRMASI | 4.06 | ₹68 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.97 | ₹7,724 | Low |
| Shelter Pharma | SHELTER | 5.45 | ₹48 | Low |
| Mono Pharmacare | MONOPHARMA | 6.51 | ₹20 | Low |
| Amwill Health Care | AMWILL | 7.33 | ₹78 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹71 | Low |
| Brooks Laboratories | BROOKS | 8.06 | ₹206 | Low |
| Royal Sense | ROYAL | 8.08 | ₹62 | Low |